Effect of Panitumumab on the Pharmacokinetics of Irinotecan

NCT00563316 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Panitumumab
DRUG: Irinotecan

Sponsor

Amgen